Certain posters like to talk about our competition, improvements in MSCs, pluripotent stem cells, EVs and such. But nobody has gotten as far as we have with the FDA when it comes to allogenic stem cell therapies, and I don’t see any on this list of what might come before the FDA in the near future.
Hard to argue that MSB is anything but the world leader in MSC therapies
Certain posters like to talk about our competition, improvements...
-
- There are more pages in this discussion • 1,885 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.5¢ |
Change
-0.025(2.58%) |
Mkt cap ! $1.078B | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.5¢ | 94.0¢ | $2.482M | 2.602M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 71720 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 10463 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |